SNTINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Senti Biosciences Holdings, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.23+0.00 (+0.84%)
Close on Oct 19, 2026
- Market cap
- $7.06M
- P/E (TTM)
- –
- Dividend yield
- –
Fundamental chart
Pick a measure to chart its full history
$22.00KFY2025, -70.1% a year since FY2021